Abstract
Decoction of Lophira lanceolata known in Hausa as Namijin Kadanya has been used by many communities in northern Nigeria for the treatment of various ailments, commonest of which is epilepsy. The current study is aimed at evaluating the claim of this medicinal plant part by herbalist for the treatment of epilepsy. A preliminary phytochemical screening was performed on the stem bark extract after which intraperitoneal LD 50 was determined in mice. Anticonvulsant screening was carried out using Maximal electroshock Test (MEST) and pentylenetetrazole (PTZ) in one day old chicks and mice respectively. Flavonoids, saponins, tannins and glycosides were found to be present. The intraperitoneal LD 50 in mice was found to be 1131.31 mg/kg. There was no significant prolongation in the latency of seizures or protection in both the MEST and PTZ model. Conversely, a significant (p.0.05) delay in the mean onset of seizures was recorded with standard drugs, sodium valproate (200 mg/kg) and phenytoin (40 mg/kg) in PTZ and MEST respectively. The findings of this study revealed that the stem bark extract of Lophira lanceolata at the doses tested do not contain any bioactive constituents that is useful in the management of epilepsy. Key words : Epilepsy, maximal electroshock, pentylenetetrazole, Lophira lanceolata
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
